Gerd Auffarth insider trades

Open-market stock purchases and sales by Gerd Auffarth, Director at Outlook Therapeutics, Inc, from SEC Form 4 filings since Aug 3, 2015.

Recent trades

DateStockTradeValue
Oct 3, 2025OTLK Outlook Therapeutics, IncBought (not open market)—

Companies traded

  • OTLK Outlook Therapeutics, Inc: other filings, last Oct 3, 2025
  • LENS Presbia plc: other filings, last Dec 17, 2018

Get free alerts when Gerd Auffarth files a new trade →